Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Preclinical Non-Human Primate Model to Test Reversible Myeloablation Following IV Busulfan Therapy without Stem Cell Rescue

Nadim Mahmud, MD PhD, Amit Khanal, MD, Simona Taioli, MS, Emre Koca, MD, Sujata Gaitonde, MD FACP, Benjamin Petro, BS, Karen Sweiss, PharmD, Damiano Rondelli, MD

Blood (2015) 126 (23): 1868.

https://doi.org/10.1182/blood.V126.23.1868.1868

Published: 2015

Journal Articles

Transient Activation Of Inflammatory Molecules By Epigenetic Modifiers Likely Plays a Role In Expansion Of Transplantable Human Cord Blood Stem/Progenitor Cells

Nadim Mahmud, MD, PhD, Benjamin Petro, BS, Xinmin Li, PhD, Simona Taioli, MS, Alvin Li, John G. Quigley, MD, Donald Lavelle, Ph.D.

Blood (2013) 122 (21): 1170.

https://doi.org/10.1182/blood.V122.21.1170.1170

Published: 2013

Journal Articles

Evaluation of Genotoxicity of Chromatin Modifying Agents Expanded Hematopoietic Graft in a Non-Human Primate Model.

Simona Taioli, MS, Benjamin Petro, BS, Sujata Gaitonde, MD, John G. Quigley, MD, Valerie Lindgren, PhD, Manuel Borce, MS, Karen Sweiss, PharmD, Damiano Rondelli, MD, Nadim Mahmud, MD, PhD

Blood (2012) 120 (21): 2994.

https://doi.org/10.1182/blood.V120.21.2994.2994

Published: 2012

Journal Articles

Possible Reduced Immunogenicity of Chromatin Modifying Agents Expanded Cord Blood Grafts Is Likely Due to STAT3 Inhibition,

Benjamin Petro, BS, Kazumi G Yoshinaga, MS, Dolores Mahmud, PhD, Simona Taioli, MS, Santosh Saraf, MD, Amer Sidani, MD, John G. Quigley, MD, Damiano Rondelli, MD, Nadim Mahmud, MD, PhD

Blood (2011) 118 (21): 4016.

https://doi.org/10.1182/blood.V118.21.4016.4016

Published: 2011

Journal Articles

Ex Vivo Expansion of Human Mobilized Peripheral Blood Stem Cells Using Epigenetic Modifiers

Santosh Saraf, MD, Hiroto Araki, MD, PhD, Benjamin Petro, BS, Kazumi G Yoshinaga, MS, Simona Taioli, MS, Amer Sidani, MD, John G. Quigley, MD, Damiano Rondelli, MD, Nadim Mahmud, MD, PhD

Blood (2011) 118 (21): 1920.

https://doi.org/10.1182/blood.V118.21.1920.1920

Published: 2011

NARROW

A Preclinical Non-Human Primate Model to Test Reversible Myeloablation Following IV Busulfan Therapy without Stem Cell Rescue

Transient Activation Of Inflammatory Molecules By Epigenetic Modifiers Likely Plays a Role In Expansion Of Transplantable Human Cord Blood Stem/Progenitor Cells

Evaluation of Genotoxicity of Chromatin Modifying Agents Expanded Hematopoietic Graft in a Non-Human Primate Model.

Possible Reduced Immunogenicity of Chromatin Modifying Agents Expanded Cord Blood Grafts Is Likely Due to STAT3 Inhibition,

Ex Vivo Expansion of Human Mobilized Peripheral Blood Stem Cells Using Epigenetic Modifiers

Email alerts

ASH Publications

American Society of Hematology

A Preclinical Non-Human Primate Model to Test Reversible Myeloablation Following IV Busulfan Therapy without Stem Cell Rescue

Transient Activation Of Inflammatory Molecules By Epigenetic Modifiers Likely Plays a Role In Expansion Of Transplantable Human Cord Blood Stem/Progenitor Cells

Evaluation of Genotoxicity of Chromatin Modifying Agents Expanded Hematopoietic Graft in a Non-Human Primate Model.

Possible Reduced Immunogenicity of Chromatin Modifying Agents Expanded Cord Blood Grafts Is Likely Due to STAT3 Inhibition,

Ex Vivo Expansion of Human Mobilized Peripheral Blood Stem Cells Using Epigenetic Modifiers

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only